Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region-Reference-Cited by-同舟云学术

Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region

Published:2014-12 Issue:1 Volume:14 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Chaubey Vikas P,Pitout Johann D D,Dalton Bruce,Gregson Daniel B,Ross Terry,Laupland Kevin B

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/s12879-014-0647-4/fulltext.html

Reference37 articles.

1. Jacoby GA, Munoz-Price LS: The new beta-lactamases. N Engl J Med. 2005, 352 (4): 380-391. 10.1056/NEJMra041359.

2. Philippon A, Arlet G, Jacoby GA: Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother. 2002, 46 (1): 1-11. 10.1128/AAC.46.1.1-11.2002.

3. Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, Simor AE, Paton S: Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother. 2005, 49 (1): 358-365. 10.1128/AAC.49.1.358-365.2005.

4. Goldstein FW: Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation. Clin Microbiol Infect. 2002, 8 (12): 823-825. 10.1046/j.1469-0691.2002.00492.x.

5. Jacoby GA: AmpC beta-lactamases. Clinical microbiology reviews. 2009, 22 (1): 161-182. 10.1128/CMR.00036-08. Table of Contents

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Patients with AmpC-Beta-Lactamase-Producing Enterobacterales Bacteremia Treated with Carbapenems versus Non-Carbapenem Regimens: A Single-Center Study;Antibiotics;2024-07-29

2. Burden and Management of Multi-Drug Resistant Organism Infections in Solid Organ Transplant Recipients Across the World: A Narrative Review;Transplant International;2024-06-17

3. Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome;Pathogens;2023-09-03

4. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections;Clinical Infectious Diseases;2023-07-18

5. Cefepime Versus Piperacillin-Tazobactam for the Treatment of Intra-Abdominal Infections Secondary to Potential AmpC Beta-Lactamase-Producing Organisms;Hospital Pharmacy;2023-05-20